Novartis Foundation

Novartis Foundation
Name	Novartis Foundation
Type	philanthropic foundation
Founded	1996
Founder	Novartis AG
Headquarters	Basel, Switzerland
Focus	global health, public health, tropical medicine

Novartis Foundation The Novartis Foundation is a Swiss-based philanthropic organization established to support global health, public health systems, and tropical medicine initiatives. It operates in concert with international agencies, academic institutions, and non-governmental organizations to implement disease-control programs and health-system strengthening projects. Its work spans infectious diseases, maternal and child health, and health workforce development across regions including sub-Saharan Africa, South Asia, and Latin America.

History

The foundation was created in the 1990s by Novartis AG following corporate restructuring that merged entities linked to Ciba-Geigy and Sandoz. Early activities drew on precedents set by the Bill & Melinda Gates Foundation, the Rockefeller Foundation, and initiatives associated with the World Health Organization and United Nations Children's Fund. During the 2000s it launched programs responding to the global burden highlighted by the Global Fund to Fight AIDS, Tuberculosis and Malaria and the Roll Back Malaria Partnership; its strategies reflected lessons from the Alma-Ata Declaration and the Millennium Development Goals. Collaborations over time included partnerships with the London School of Hygiene & Tropical Medicine, the Institute of Tropical Medicine (Antwerp), and the Swiss Tropical and Public Health Institute.

Mission and objectives

The foundation's stated mission aligns with frameworks advanced by World Health Organization and policy approaches seen in documents from the World Bank and United Nations Development Programme. Objectives emphasize control and elimination of neglected tropical diseases targeted by the London Declaration on Neglected Tropical Diseases and support for health systems strengthening as articulated in reports from the Global Health Security Agenda and the Commission on Social Determinants of Health. Priority areas include capacity building comparable to programs at the Harvard T.H. Chan School of Public Health, operational research like that at the Institute for Health Metrics and Evaluation, and implementation science promoted by the US National Institutes of Health.

Programs and initiatives

Programs have included mass drug administration campaigns similar to efforts by the Clinton Health Access Initiative, pilot projects in integrated community case management reflecting models from Save the Children, and training programs for midwives and nurses resembling curricula at the University of Cape Town and Makerere University. Disease-specific initiatives have targeted malaria control paralleling strategies from the President's Malaria Initiative and schistosomiasis and leprosy control in coordination with partners following the World Health Assembly resolutions. Health-systems pilots have drawn on digital-health innovations promoted by PATH and supply-chain strengthening approaches used by UNICEF and the Gavi, the Vaccine Alliance.

Governance and funding

Governance combines corporate philanthropy practices seen at Johnson & Johnson and Pfizer foundations with oversight patterns similar to those of the Wellcome Trust and the Open Society Foundations. Boards have included representatives from academic centers such as the University of Oxford, policy experts from the European Commission, and public-health leaders affiliated with the London School of Hygiene & Tropical Medicine and the Swiss Federal Institute of Technology in Zurich. Funding sources have historically included endowments from Novartis AG and programmatic co-financing with multilateral organizations like the World Bank and bilateral donors such as the United States Agency for International Development and the Department for International Development.

Partnerships and collaborations

Strategic collaborations span intergovernmental bodies and civil-society groups: joint work with the World Health Organization, programmatic alliances with Médecins Sans Frontières, and operational linkages with The Global Fund to Fight AIDS, Tuberculosis and Malaria. Academic partnerships have involved the Imperial College London, the University of Washington, and the Karolinska Institutet. The foundation has engaged in public–private partnerships mirroring structures used by the Global Alliance for Vaccines and Immunization and coalitions convened by the Bill & Melinda Gates Foundation and the Wellcome Trust.

Impact and evaluation

Evaluations have been undertaken using methods common to impact assessments by the Cochrane Collaboration and metrics aligned with the Global Burden of Disease studies coordinated by the Institute for Health Metrics and Evaluation. Reported outcomes include reductions in prevalence of targeted tropical diseases in pilot districts, strengthened clinical training outputs comparable to programs at the London School of Hygiene & Tropical Medicine, and improved supply-chain metrics similar to those achieved by UNICEF vaccine programs. External reviews have cited the importance of alignment with national ministries such as the Ministry of Health (Kenya) and the Ministry of Health and Family Welfare (India) and recommended sustained financing models resembling those advocated by the World Bank and the International Monetary Fund for program continuity.

Category:Foundations based in Switzerland Category:Global health organizations